UMIP wins Tech Transfer Award
UMIP Wins Tech Transfer Award
The University of Manchester’s intellectual property commercialisation company, UMIP, was voted Technology Transfer Office of the Year at the Genesis biotechnology conference in London last week.
The judges at the Gala dinner, held at the Queen Elizabeth II Conference Centre, awarded UMIP the top prize, despite strong competition from the other two shortlisted companies; Cancer Research Technology Ltd and UCL
UMIP announce new Entrepreneur in Residence
PRESS RELEASE – DATED 3rd Dec 09
The University of Manchester’s award winning intellectual property company (UMIP) is pleased to announce the appointment of Dr Sharon O’ Kane as its Entrepreneur in Residence. Sharon will be engaging in an advisory role with UMIP to enhance the University’s spin-out company and licensing activities and to encourage intellectual property entrepreneurship at the University.
Sharon, who was re
BioNoW Newsletter – March 2010
Novartis collaboration boosts EpistemEpistem, the biotechnology and research company based in Manchester, has posted a 90 per cent rise in like-for-like sales for the six months to 31 December, boosted by a research and development contract signed with pharmaceutical giant Novartis last April. The company posted a turnover of £2.8m for the period, up from £1.5m a year earlier. High staff numbers in its novel therapies division, which supports the Novarti
UMIC Continues to Drive Success in the Innovation Voucher Scheme
To date UMIC is assisting over 54 small businesses in the Northwest with the NWDA Innovation Voucher Scheme.
Take a look at UMIC downloads for case studies.
Introduced by the NWDA as part of their business support package to local firms in the downturn, each innovation voucher is worth £3k with a number of £7k vouchers now available. Companies can use this money for consultancy services or for pump-priming new proje
BioNow March Newsletter
Companies
Positive outlook for woundcare groupAdvanced Medical Solutions (AMS), a developer and manufacturer of products for the woundcare market, has posted a pre-tax profit rise of 54 per cent to £2.9m for the year to 31 December. The Winsford based company has also increased group revenue by 21 per cent to £20.3m thanks to a broader global customer base and an enhanced technology portfolio. Revenue soars at EpistemMancheste
